These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17683479)

  • 21. Adenovirus vector-mediated assay system for hepatitis C virus replication.
    Yoshida T; Kondoh M; Ojima M; Mizuguchi H; Yamagishi Y; Sakamoto N; Yagi K
    Nucleic Acids Res; 2011 May; 39(10):e64. PubMed ID: 21306994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential applications of siRNA in hepatitis C virus therapy.
    Smolic R; Volarevic M; Wu CH; Wu GY
    Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
    Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
    Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.
    Chandra PK; Kundu AK; Hazari S; Chandra S; Bao L; Ooms T; Morris GF; Wu T; Mandal TK; Dash S
    Mol Ther; 2012 Sep; 20(9):1724-36. PubMed ID: 22617108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a.
    Sakurai F; Furukawa N; Higuchi M; Okamoto S; Ono K; Yoshida T; Kondoh M; Yagi K; Sakamoto N; Katayama K; Mizuguchi H
    Virus Res; 2012 May; 165(2):214-8. PubMed ID: 22342424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A human liver cell line exhibits efficient translation of HCV RNAs produced by a recombinant adenovirus expressing T7 RNA polymerase.
    Aoki Y; Aizaki H; Shimoike T; Tani H; Ishii K; Saito I; Matsuura Y; Miyamura T
    Virology; 1998 Oct; 250(1):140-50. PubMed ID: 9770428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subgenomic replicon derived from a cell line infected with the hepatitis C virus.
    Kishine H; Sugiyama K; Hijikata M; Kato N; Takahashi H; Noshi T; Nio Y; Hosaka M; Miyanari Y; Shimotohno K
    Biochem Biophys Res Commun; 2002 May; 293(3):993-9. PubMed ID: 12051758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of HCV RNA replication by baculovirus-mediated shRNA expression.
    Suzuki H; Kaneko H; Tamai N; Miyano-Kurosaki N; Hashimoto K; Shimotohno K; Takaku H
    Nucleic Acids Symp Ser (Oxf); 2005; (49):339-40. PubMed ID: 17150772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiviral activities of ISG20 against hepatitis C virus].
    Xu H; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):33-7. PubMed ID: 23663760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression.
    Lonze BE; Holzer HT; Knabel MK; Locke JE; DiCamillo GA; Karhadkar SS; Montgomery RA; Sun Z; Warren DS; Cameron AM
    Arch Surg; 2012 Apr; 147(4):384-7. PubMed ID: 22508787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
    Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
    J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A galactose-functionalized dendritic siRNA-nanovector to potentiate hepatitis C inhibition in liver cells.
    Lakshminarayanan A; Reddy BU; Raghav N; Ravi VK; Kumar A; Maiti PK; Sood AK; Jayaraman N; Das S
    Nanoscale; 2015 Oct; 7(40):16921-31. PubMed ID: 26411288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulated and liver-specific tamarin alpha interferon gene delivery by a helper-dependent adenoviral vector.
    Aurisicchio L; De Tomassi A; La Monica N; Ciliberto G; Traboni C; Palombo F
    J Virol; 2005 Jun; 79(11):6772-80. PubMed ID: 15890916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.
    Lavender H; Brady K; Burden F; Delpuech-Adams O; Denise H; Palmer A; Perkins H; Savic B; Scott S; Smith-Burchnell C; Troke P; Wright JF; Suhy D; Corbau R
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1364-75. PubMed ID: 22203606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.
    Ali N; Allam H; May R; Sureban SM; Bronze MS; Bader T; Umar S; Anant S; Houchen CW
    J Virol; 2011 Dec; 85(23):12292-303. PubMed ID: 21937640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus-mediated shRNA interference against HSV-1 replication in vitro.
    Song B; Liu X; Wang Q; Zhang R; Yang T; Han Z; Xu Y
    J Neurovirol; 2016 Dec; 22(6):799-807. PubMed ID: 27566181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-mediated shRNA interference against porcine circovirus type 2 replication both in vitro and in vivo.
    Feng Z; Jiang P; Wang X; Li Y; Jiang W
    Antiviral Res; 2008 Mar; 77(3):186-94. PubMed ID: 18199493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of virus-associated RNAs.
    Machitani M; Sakurai F; Katayama K; Tachibana M; Suzuki T; Matsui H; Yamaguchi T; Mizuguchi H
    Virus Res; 2013 Dec; 178(2):357-63. PubMed ID: 24055658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA.
    Vlassov AV; Korba B; Farrar K; Mukerjee S; Seyhan AA; Ilves H; Kaspar RL; Leake D; Kazakov SA; Johnston BH
    Oligonucleotides; 2007; 17(2):223-36. PubMed ID: 17638526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.